Paper38726720
Defining high bleeding risk in patients undergoing transcatheter aortic valve implantation: a VARC-HBR consensus document.
Garot P and 30 others. EuroIntervention, 2024. Cited by 19 papers, by iCite.
Cite this record
ConductScience Library. Defining high bleeding risk in patients undergoing transcatheter aortic valve implantation: a VARC-HBR consensus document. Papers, record 38726720. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38726720
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Defining high bleeding risk in patients undergoing transcatheter aortic valve implantation: a VARC-HBR consensus document.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Transcatheter Aortic Valve Replacement | Major topic |
| Hemorrhage | Major topic |
| Humans | |
| Risk Factors | |
| Risk Assessment | |
| Aortic Valve Stenosis | |
| Aortic Valve |
Source PubMed
References131
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 36130256 | The search for optimal antithrombotic therapy in transcatheter aortic valve implantation: facts and uncertainties. | Eur Heart J | 2022 | https://conductscience.org/library/papers/36130256 | PubMed |
| 2 | 28315573 | Mortality, Length of Stay, and Cost Implications of Procedural Bleeding After Percutaneous Interventions Using Large-Bore Catheters. | JAMA Cardiol | 2017 | https://conductscience.org/library/papers/28315573 | PubMed |
| 3 | 30621982 | Transcatheter Aortic Valve Replacement in Oncology Patients With Severe Aortic Stenosis. | JACC Cardiovasc Interv | 2019 | https://conductscience.org/library/papers/30621982 | PubMed |
| 4 | 30065928 | Access Sites for TAVI: Patient Selection Criteria, Technical Aspects, and Outcomes. | Front Cardiovasc Med | 2018 | https://conductscience.org/library/papers/30065928 | PubMed |
| 5 | 22726400 | 30 days and midterm outcomes of patients undergoing percutaneous replacement of aortic valve according to their renal function: a multicenter study. | Int J Cardiol | 2013 | https://conductscience.org/library/papers/22726400 | PubMed |
| 6 | 36153179 | The Usefulness of the Modified Essential Frailty Toolset to Predict Late Bleeding Events after Transcatheter Aortic Valve Implantation. | Am J Cardiol | 2022 | https://conductscience.org/library/papers/36153179 | PubMed |
| 7 | 31116032 | Defining High Bleeding Risk in Patients Undergoing Percutaneous Coronary Intervention. | Circulation | 2019 | https://conductscience.org/library/papers/31116032 | PubMed |
| 8 | 27026020 | 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention, 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery, 2012 ACC/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease, 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction, 2014 AHA/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes, and 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery. | Circulation | 2016 | https://conductscience.org/library/papers/27026020 | PubMed |
| 9 | 22083020 | Transcatheter aortic valve implantation: current and future approaches. | Nat Rev Cardiol | 2011 | https://conductscience.org/library/papers/22083020 | PubMed |
| 10 | 24657695 | Transcatheter aortic valve replacement using a self-expanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgery. | J Am Coll Cardiol | 2014 | https://conductscience.org/library/papers/24657695 | PubMed |
| 11 | 28965713 | Predictors of 1-Year Mortality After Transcatheter Aortic Valve Implantation in Patients With and Without Advanced Chronic Kidney Disease. | Am J Cardiol | 2017 | https://conductscience.org/library/papers/28965713 | PubMed |
| 12 | 20961243 | Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. | N Engl J Med | 2010 | https://conductscience.org/library/papers/20961243 | PubMed |
| 13 | 27040324 | Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients. | N Engl J Med | 2016 | https://conductscience.org/library/papers/27040324 | PubMed |
| 14 | 23707321 | Prognostic value of chronic kidney disease after transcatheter aortic valve implantation. | J Am Coll Cardiol | 2013 | https://conductscience.org/library/papers/23707321 | PubMed |
| 15 | 27053442 | Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis. | Lancet | 2016 | https://conductscience.org/library/papers/27053442 | PubMed |
| 16 | 32727528 | Influence of transcatheter aortic valve replacement on patients with severe aortic stenosis undergoing non-cardiac surgery. | J Cardiothorac Surg | 2020 | https://conductscience.org/library/papers/32727528 | PubMed |
| 17 | 36211566 | Are cardiovascular comorbidities always associated with a worse prognosis in patients with lung cancer? | Front Cardiovasc Med | 2022 | https://conductscience.org/library/papers/36211566 | PubMed |
| 18 | 27142257 | Baseline anemia and its impact on midterm outcome after transcatheter aortic valve implantation. | Catheter Cardiovasc Interv | 2017 | https://conductscience.org/library/papers/27142257 | PubMed |
| 19 | 30883058 | Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients. | N Engl J Med | 2019 | https://conductscience.org/library/papers/30883058 | PubMed |
| 20 | 36599591 | No Antithrombotic Therapy After Transcatheter Aortic Valve Replacement: Insight From the OCEAN-TAVI Registry. | JACC Cardiovasc Interv | 2023 | https://conductscience.org/library/papers/36599591 | PubMed |
Cited by11
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 19 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42356150 | Transcatheter Aortic Valve Implantation in Cancer Patients: A Contemporary Review of the Specific Challenges, the Outcomes, Risk Stratification, and Decision-Making. | Medicina (Kaunas) | 2026 | https://conductscience.org/library/papers/42356150 | PubMed |
| 41827184 | Thrombotic Versus Bleeding Risk After Transcatheter Aortic Valve Implantation. | J Clin Med | 2026 | https://conductscience.org/library/papers/41827184 | PubMed |
| 41367365 | Nationwide Analysis of PCI After TAVR From the Netherlands Heart Registration. | Catheter Cardiovasc Interv | 2026 | https://conductscience.org/library/papers/41367365 | PubMed |
| 41156021 | Definition, Incidence, Prediction, and Prevention of Bleeding Events After Transcatheter Aortic Valve Implantation. | J Clin Med | 2025 | https://conductscience.org/library/papers/41156021 | PubMed |
| 40958622 | An ongoing quest to discern the optimal antithrombotic therapy after TAVI. | EuroIntervention | 2025 | https://conductscience.org/library/papers/40958622 | PubMed |
| 40958621 | VARC-HBR criteria validation in TAVI patients on oral anticoagulation. | EuroIntervention | 2025 | https://conductscience.org/library/papers/40958621 | PubMed |
| 40819859 | Rationale and design of SCOPE trial: a prospective, multicentre, open-label, randomised controlled trial to evaluate the overall efficacy and safety of a short-term anticoagulation strategy versus conventional single antiplatelet therapy in patients with severe aortic stenosis without indications for anticoagulation or dual antiplatelet therapy post-transcatheter aortic valve replacement. | BMJ Open | 2025 | https://conductscience.org/library/papers/40819859 | PubMed |
| 40430236 | Complex Transfemoral Access During Transcatheter Aortic Valve Replacement: A Narrative Review of Management, Complexity Scores, and Alternative Access. | Life (Basel) | 2025 | https://conductscience.org/library/papers/40430236 | PubMed |
| 40118800 | Rationale and Design of the CREATE Trial: A Multicenter, Randomized Comparison of Continuation or Cessation of Single Antithrombotic Therapy at 1 Year After Transcatheter Aortic Valve Replacement. | J Am Heart Assoc | 2025 | https://conductscience.org/library/papers/40118800 | PubMed |
| 39475194 | Validation of the Valve Academic Research Consortium High Bleeding Risk Definition in Patients Undergoing TAVR. | Circ Cardiovasc Interv | 2025 | https://conductscience.org/library/papers/39475194 | PubMed |
| 39252142 | Outcomes of patients with active cancer after transcatheter aortic valve replacement: an updated meta-analysis. | Cardiooncology | 2024 | https://conductscience.org/library/papers/39252142 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/38726720
GET https://conductscience.org/api/papers/v1/38726720/authors?page=2